Are people immune if they catch and recover from Covid-19?
Latest Medical News
Covid-19 Workers Receive Training to Protect Their Own Health
The National Institutes of Health will launch a website with important educational resources for coronavirus workers dealing with the spread of COVID-19.
Loss of Sense of Smell or Taste May be Covid-19 Symptom
A loss of a sense of smell or taste may be a symptom of COVID-19, medical groups representing ear, nose and throat specialists have warned.
Digest Symptoms and Covid-19
Digestive symptoms are common in coronavirus disease 2019 (COVID-19), occurring as the chief complaint in nearly half of patients presenting to hospital, according to a new study.
FDA News & Alerts
FDA Takes Action to Increase U.S. Supply of Personal Protective Equipment for Covid-19
The U.S. Food and Drug Administration (FDA) took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturers importing personal protective equipment and other devices.
Final FDA Guidance Issued on Evaluation and Labeling of Abuse-deterrent Opioids
The U.S. Food and Drug Administration today issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.
Use of CoreValve System for Aortic “Valve-in-Valve” Replacement Expanded
The U.S. Food and Drug Administration today expanded the approved use of the CoreValve System to treat certain patients who have previously had a tissue aortic valve replacement and are in need of a second one.
Breath Test to Aid in Diagnosis of Gastroparesis Gets FDA Approval
The U.S. Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis.
Drug Industry News
Lawmakers Aim to Curb Skyrocketing Generic Drug Prices
Two prominent lawmakers are following through on a promise to do something about recent rises in generic drug prices, with identical House and Senate bills that would force generic drugmakers to pay state Medicaid rebates when prices rise faster than inflation.
EMA Reviewing Pneumonia Risk With Inhaled Corticosteroids
The European Medicines Agency is taking a hard look at whether patients taking inhaled corticosteroids for chronic obstructive pulmonary disease are at higher risk for pneumonia.
FDA Approves Janssen’s Schizophrenia Injection Invega Trinza
Janssen Pharmaceuticals plans to make its long-acting atypical schizophrenia therapy Invega Trinza commercially available by mid-June, following FDA approval Monday.
Two More Compounders Warned for Poor Sterile Drug Manufacturing
Compounding pharmacies continue to be plagued by sterility issues, as the FDA handed warning letters to facilities in Florida and Kentucky — bringing to nine the number of compounders cited for such deficiencies since October.
India Warns Drugmakers Again to Register in Online Database
India’s drug price regulator is again warning drugmakers to immediately register in an online database or face fines and imprisonment.